RBM15 and gestational diabetes: In gestational diabetes (GDM), the researchers found that the overall mRNA m6A methylation level in the fetal liver of the mouse was significantly increased by constructing a GDM mouse model, and in vitro experiments revealed that RBM15 mediated m6A modification affected the insulin sensitivity of offspring by regulating the expression of CLDN4, leading to metabolic syndrome (160).